关于全州制药师为戒烟药物开处方的全州协议的利益关方反
Lindsey Votaw1, Karen Suchanek Hudmon2, Tiffany R Shin3
1Population Health, University of Kansas School of Medicine, Wichita, KS, United States of America.
大多数堪萨斯州的烟草控制利益相关者支持药剂师开处方戒烟产品的政策. 反将完善该协议,以获得更广泛的接受和更好的吸烟戒烟辅助器.
科学领域:
- 公共卫生 公共卫生
- 卫生政策 卫生政策
- 药房实践 在药房实践.
背景情况:
- 戒烟对于美国的公共健康和经济福祉至关重要.
- 在堪萨斯州这样的农村地区,获得基于证据的烟草治疗是有限的.
- 在堪萨斯州,大多数戒烟的尝试都是无助的,因为获得咨询和药物的机会有限.
研究的目的:
- 评估利益相关者对堪萨斯州拟议的全州政策的看法.
- 评估对处方戒烟药物的药剂师的支持.
- 收集关于药剂师领导的戒烟协议的模型语言的反.
主要方法:
- 在堪萨斯州,向烟草控制利益相关者分发了一份横截面调查.
- 受访者审查并提供了关于药剂师发放戒烟产品的协议的反.
- 数据分析确定了支持的部分,并总结了协议修改的反.
主要成果:
- 完成了15项调查,代表了堪萨斯州各种利益相关者组织和药房.
- 收到重要的反的关键部分包括介绍,目的,药剂师资格,产品,健康查和患者转诊.
- 大多数受访者表示支持全州协议,使药剂师能够开处方戒烟产品.
结论:
- 堪萨斯州的利益相关者似乎支持一项全州范围的协议,要求药剂师开处方戒烟产品.
- 收到的反将用于修改协议,旨在获得利益相关方的相互接受.
- 修订后的协议有可能在堪萨斯州增加获得戒烟援助的机会.
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
相关概念视频
Drug Regulation
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Acute Coronary Syndrome IV: Interprofessional Care
Drug Control Governance: Regulatory Bodies and Their Impact
